Idexx Laboratories (IDXX) Total Non-Current Liabilities (2009 - 2026)

Idexx Laboratories has reported Total Non-Current Liabilities for 18 years, with the latest figure at $542.1 million in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities fell 16.35% year-over-year to $542.1 million in Q2 2026; TTM through Jun 2026 was $542.1 million, a 16.35% decrease from a year earlier, with the FY2025 full-year figure at $596.6 million, down 5.34% from the prior year.
• Total Non-Current Liabilities was $542.1 million for Q2 2026 at Idexx Laboratories, up from $529.5 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $983.6 million in Q2 2022, with the low at $529.5 million in Q1 2026.
• Average Total Non-Current Liabilities over 5 years is $761.0 million, with a median of $771.1 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities decreased 2.17% in 2022, then decreased 23.95% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $902.2 million in 2022, then declined by 8.69% to $823.8 million in 2023, then declined by 23.5% to $630.2 million in 2024, then retreated by 5.34% to $596.6 million in 2025, then dropped by 9.13% to $542.1 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $542.1 million (Q2 2026), $529.5 million (Q1 2026), and $596.6 million (Q4 2025), per Business Quant data.